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HIV Rev uses a conserved cellular protein export pathway for the
nucleocytoplasmic transport of viral RNAs
Christian C. Fritz and Michael R. Green
Background: The structural proteins of human immunodeficiency virus type 1
(HIV-1) are encoded by intron-containing mRNAs that normally are retained in
the nucleus. A viral regulatory protein, Rev, specifically induces the accumulation
of these transcripts in the cytoplasm. Rev is an RNA-binding protein that also
contains an ‘effector’ domain. The Rev effector domain has recently been shown
to function as an autonomous nuclear export signal (NES) that, when fused to a
foreign protein, will cause its rapid nuclear export. We and others have recently
reported the cloning of a human protein (hRIP/Rab), that specifically interacts
with the effector domain of Rev.
Results: Here we show that the NESs contained within two cellular proteins, PKI
and IkB, which are not involved in RNA metabolism, also interact with hRIP.
Fusion of these cellular sequences to the Rev RNA-binding domain reconstitutes
a functional Rev protein. In addition to hRIP, these NESs also bind to several
nuclear pore proteins located on the nucleoplasmic, membrane, and cytoplasmic
side of the nuclear pore complex (NPC). We show that this protein export
pathway is highly conserved by demonstrating that mammalian NESs also
function in yeast.
Conclusions: Our results indicate that the HIV-1 Rev protein evolved to take
advantage of a cellular protein export pathway in order to allow the
nucleocytoplasmic transport of unspliced viral RNA. Our data suggest a model in
which the export substrate is translocated through the NPC by sequential
interactions with different nucleoporins. Finally, our experiments suggest a
mechanism by which IkB can downregulate nuclear NFkB activity by causing its
rapid export from the nucleus.
Background
In the eukaryotic cell, the nuclear genome is separated
from the cytoplasm by a double membrane. Although this
arrangement allows the cell an additional level of regula-
tion, a steady stream of macromolecules must be trans-
ported into and out of the nucleus. In recent years, much
has been learned about protein import into the nucleus.
Proteins destined for the interior of the nucleus contain
short signal sequences, termed nuclear localization signals
(NLSs), which bind to a dimeric complex of cytoplasmic
receptor proteins (importins/karyopherins) that mediate
docking at and translocation through the nuclear pore
complex (NPC; for review see [1–3]).
Much less is currently known about the equally important
process that exports RNAs and proteins from the nucleus
[3,4]. An important model system for the study of mRNA
nuclear transport is the post-transcriptional regulation of
human immunodeficiency virus type 1 (HIV-1) gene
expression. The structural proteins of this virus are
encoded by large, intron-containing transcripts, and the
virus has evolved a mechanism that selectively allows
unspliced viral, but not cellular, mRNAs to accumulate in
the cytoplasm. This pathway is mediated by the viral Rev
protein, an RNA-binding protein that binds specifically to
an RNA element present in all unspliced viral transcripts.
Mutational analysis has identified a domain at the  carboxyl
terminus of Rev — the ‘effector domain’ — which is dis-
tinct from the RNA-binding domain and is essential for the
RNA-bound Rev protein to function (for review see [5,6]).
This effector domain has recently been identified as a
nuclear export sequence (NES) which, in a manner analo-
gous to NLSs, induces rapid nuclear export when fused to a
foreign protein [7]. The human cellular protein hRIP/Rab
specifically interacts with the Rev effector domain, and has
the properties expected of a Rev cellular co-factor [8,9].
Taylor and coworkers [10] have independently identified
an autonomous NES as part of the thermostable inhibitor
protein, PKI, of protein kinase A (PKA). Intriguingly, both
the Rev NES and the PKI NES contain several leucine
residues that have been shown to be essential for their
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function. This raises the possibility that these two signals,
which serve disparate functions, use the same nuclear
export pathway. To address this question, we have tested
whether the PKI NES, like the Rev NES, can bind to
hRIP. Here, we report that the PKI NES can interact with
hRIP and, like the Rev NES, also interacts with several
subunits of the NPC. We also show, by domain-swap
experiments, that the PKI NES can functionally replace
the Rev effector domain. These results suggest that the
effector domain of Rev evolved to mimic a cellular NES,
allowing the virus to use a cellular protein export pathway
for the transport of unspliced viral transcripts.
Results
The PKI NES and a putative NES in IkB interact with hRIP
A short sequence within the cellular inhibitor of PKA has
been identified as an autonomous NES [10]; a related
sequence is present at the carboxyl terminus of the IkBa
protein [10]. Although these sequences do not display a
high degree of identity with each other or with the Rev
effector domain, all three sequences are rich in leucine
residues and, in the case of Rev and PKI, it has been
shown that some of these leucines are essential for func-
tion (see Fig. 1c). These similarities raise the possibility
that all three leucine-rich elements belong to the same
class of NES and may interact with a similar set of cellular
proteins mediating NES-directed export from the nucleus. 
To test the hypothesis that the leucine-rich sequences
present in PKI and IkB are NESs that use the same
nuclear export pathway as HIV-1 Rev, we first asked
whether these sequences interact with hRIP/Rab [8,9].
Using a yeast two-hybrid assay, we determined that both
the PKI and the IkB sequences interact with wild-type
but not mutant hRIP (Fig. 1a). Also shown in Figure 1a is
the previously demonstrated interaction of hRIP with the
human T-cell leukemia virus type 1 (HTLV-I) Rex
protein, which contains an effector domain functionally
equivalent to that of HIV Rev [11,12]. 
The PKI NES has been analyzed in detail by site-directed
mutagenesis [10]. To test the significance of the inter-
action between hRIP and the PKI NES, we analyzed
several substitution mutants that lacked NES activity and
found a perfect correlation between NES activity and
hRIP binding (Fig. 1b). Alignment of the Rev, PKI, IkB
and Rex sequences shows that the only feature in common
between these sequences is a set of characteristically
spaced leucine or isoleucine residues (Fig. 1c). Using our
binding data together with previously published functional
data [10,13], it is possible to distinguish between an almost
invariable core of the sequence LxxLxL (amino-acid single
letter code, where ‘x’ denotes any residue) and more irreg-
ularly spaced amino-terminal leucines (dotted squares in
Fig. 1c). Core leucine residues are characterized by the fact
that single point mutations at these positions abolish NES
function and hRIP binding (for example, Rev mutants
M27, M28 and M29) [8,13]. Individual amino-terminal
leucines are not essential, and their positions can vary in
relation to the core; however, deletion of all upstream
leucine residues also results in a non-functional NES (for
example, Rev D9/19, [13]). In the case of IkB, our align-
ment shows that a single isoleucine seems to fulfil the
function of these amino-terminal hydrophobic residues.
IkB and PKI contain NESs that can functionally replace the
Rev effector domain
We next asked whether the leucine-rich sequences present
in PKI and IkB could functionally substitute for the Rev
effector domain. Hybrid proteins were constructed, fusing
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Figure 1
The PKI NES and the putative NES in IkB interact specifically with
hRIP. (a) Two-hybrid interactions between LexA–NES fusion proteins
and hRIP derivatives tagged with a transcriptional activation domain.
(b) Comparison between export activity and hRIP binding for PKI
mutants, whose substituted residues are shown. The data for export
are from [10]. Binding to hRIP was determined in a two-hybrid assay.
(c) Sequence alignment of leucine-rich NESs. Asterisks denote
residues in which a single substitution abolishes NES function [10,13].
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the Rev RNA-binding domain (RBD) in-frame to amino
acids 35–47 of PKI (RBD–PKI) and to amino acids
263–281 of IkBa (RBD–IkB). These fusion proteins were
tested for Rev activity using a reporter construct that con-
tains the chloramphenicol acetyl transferase (CAT) coding
sequence and a Rev-binding site in an intron, allowing the
translation of CAT only from messages that reach the cyto-
plasm unspliced [14]. Both fusion proteins were fully func-
tional for Rev-mediated RNA export (Fig. 2, compare
lanes 4 and 6 with lane 2), whereas a fusion protein con-
taining the single point mutant PKI P12 (see Fig. 1b),
which does not bind to hRIP, displayed no Rev function
(Fig. 2, lane 5). These results not only show that IkB con-
tains a functional NES, but also that both cellular NESs
can functionally replace the Rev effector domain for the
export of pre-mRNA from the nucleus. 
Cellular and viral NESs interact with multiple components
of the NPC
The region of hRIP that interacts with the Rev NES con-
tains repeats of the two amino acids phenylalanine and
glycine (FG repeats), which are similar to the repeat
regions of a class of nuclear pore proteins [15]. The FG
repeat region of hRIP is responsible for interaction with
the Rev effector domain [8]. Stutz et al. [16] have shown
that the Rev NES can interact with several nucleoporins,
although the positions of these nucleoporins within the
NPC are unknown. It is not clear, therefore, whether
there is a functional redundancy between FG repeat-con-
taining proteins in nuclear export, or whether an NES
interacts sequentially with different nucleoporins while
being transported through the NPC. 
We analyzed the interaction of NESs with the repeat
regions of several nucleoporins that have been localized
within the NPC by electron microscopy (see Fig. 5): the
mammalian proteins Nup153 and Nup98, which reside on
the nucleoplasmic side of the NPC [17,18]; the rat protein
Pom121, which is a pore membrane protein [19]; and two
proteins that are located at the cytoplasmic face of the
NPC, yeast Nup159 and human Nup214 [20,21]. The FG
repeat regions of these proteins were fused to a transcrip-
tional activation domain, and transformed together with
the indicated LexA fusion proteins into a yeast strain con-
taining an integrated lacZ reporter gene. Interaction of
the respective fusion proteins resulted in the develop-
ment of blue dye on medium containing the colour indi-
cator X-Gal. This matrix of two-hybrid interactions
showed that all FG repeat-containing nucleoporins that
we tested interacted with each of the NESs, albeit with
different intensities (Fig. 3a). Interestingly, most of the
nucleoporins appeared to interact more strongly with
NESs than hRIP. Note that the yeast strain containing
the LexA–Rev and Nup159 fusion proteins turned blue
after prolonged incubation on medium containing X-Gal
(see also Fig. 3b). This very weak interaction between
Rev and the yeast nucleoporin Nup159, as compared with
that between and the other NESs, might explain why
Rev works poorly in Saccharomyces cerevisiae [22].
To investigate the specificity of these interactions, we
tested the interaction of these nucleoporins with a panel
of Rev effector-domain mutants, which have been charac-
terized for Rev function [13]. As described previously for
hRIP [8], there was a perfect correlation between Rev
function (wild-type, M20 and M25) and binding to the
repeat regions of the nucleoporins tested (Fig. 3b). Rev
mutants that lacked activity (M10, M22, and the two point
mutants, M27 and M29, which eliminate single leucine
residues at positions 78 and 83 of the Rev NES, respec-
tively; see Fig. 1c) did not interact with the repeat regions,
not even with those of Nup153 and Nup214 (which inter-
acted very strongly with functional Rev effector domains).
The PKI NES is also functional in yeast
Many cellular processes are conserved between yeast and
humans. Rev has been reported to function at a low level
in yeast [22]; consistent with this study, we found that the
Rev NES interacted very weakly with yeast Nup159 com-
pared with the other mammalian NESs tested (Fig. 3a). To
ask whether the NES within PKI was functional in yeast,
we constructed two fusion proteins with the LexA DNA-
binding domain and a transcriptional activation region (Fig.
4a): one fusion protein also contained the PKI NES; the
second also contained the P12 mutant version of the PKI
NES, which does not bind hRIP and has no NES activity
(see Figs 1b and 2). If the PKI NES were functional in
Figure 2
PKI and IkB contain NESs that can functionally substitute for the Rev
effector domain. CV1 cells were transfected with 0.5 mg of the CAT
reporter CM128 [14] and 1 mg of the indicated Rev derivatives using
the calcium-phosphate technique. RBD-fusions: the PKI, the PKI
mutant P12, or the IkB NES were fused at amino acid 77 to the Rev
RNA-binding domain (RBD).
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yeast, one would expect the fusion protein containing the
wild-type NES to be exported constantly to the cyto-
plasm, whereas the other fusion protein would remain in
the nucleus. In the steady-state, this should result in a
higher transcriptional activation of a reporter gene under
LexA control by the fusion protein containing the mutant
PKI NES. As shown in Figure 4b, we found these predic-
tions to be the case; in fact, the fusion protein with the
wild-type PKI NES was exported from the yeast nucleus
so efficiently that we detected very little reporter-gene
activation.
Discussion
The recent identification of a cellular co-factor for HIV
Rev, hRIP/Rab [8,9], raises the question as to its normal
cellular function. Here, we report that the NESs of two
cellular proteins, PKI and IkB, also interact specifically
with hRIP and can functionally substitute for the Rev
effector domain. These results imply that hRIP is part of a
cellular pathway for protein export from the nucleus. Curi-
ously, both natural substrates for hRIP identified so far
appear to play a negative regulatory role in signal transduc-
tion. Although the role of PKI has not been elucidated
fully [23], this protein can enter the nucleus independently
and can then inhibit the nuclear functions of the cAMP
dependent protein kinase (PKC) by two mechanisms: first,
binding by PKI inhibits the activity of the catalytic subunit
(C) of the kinase [24]; and second, upon binding, the NES
on PKI becomes exposed and triggers the rapid export of
the PKI–C complex from the nucleus [25].
A new function for IkB 
IkB negatively regulates members of the Rel family of
transcription factors. Apart from its previously recognized
ability to mask the NLS of NFkB, our results suggest that
IkB might work similarly to PKI. IkB can enter the
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Figure 4
The PKI NES is functional in S. cerevisiae. (a) Constructs used. AD;
acidic transcriptional activation domain from the pseudorabies virus
immediate early protein, residues 1–34 [38]. (b) Transcriptional
activation by LexA and LexA fusion proteins in S. cerevisiae. A yeast
strain containing an integrated lexAop-lacZ construct was
transformed with plasmids encoding the indicated constructs and
liquid b-galactosidase (b-Gal) assays were performed in triplicate.
b-galactosidase activity is in nmoles minute–1 mg–1 protein; error bars
represent the standard deviation.
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Figure 3
NESs interact with multiple nucleoporins. (a) Two-hybrid interactions
between LexA–NES fusion proteins and repeat regions of the indicated
nucleoporins tagged with a transcriptional activation domain. (b)
Interaction of nucleoporin repeat regions with a panel of mutants in the
Rev NES. Two-hybrid interactions between activation-domain-tagged
nucleoporins and LexA–Rev fusions are shown. Signs in parentheses
indicate whether these mutants retain Rev function (from [13]).
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nucleus independently [26,27] and, by binding to NFkB,
can dissociate NFkB from its binding site on DNA [28]. By
analogy to PKI, binding would then expose the leucine-
rich region on IkB, which we have shown is a functional
NES. This would result in the net expulsion of the
IkB–NFkB complex from the nucleus, creating a classical
negative feedback loop: treatment of cells with inducer
(tumour necrosis factor (TNF), phorbol ester (PMA), inter-
leukin-1 (IL-1), ultraviolet light and so on) leads to nuclear
accumulation of NFkB via rapid degradation of IkB; IkB
synthesis is, in turn, strongly induced by nuclear NFkB
[29], and this newly synthesized IkB accumulates in the
nucleus [30] where it induces the rapid export of NFkB to
the cytoplasm. This model is consistent with several obser-
vations in the literature. First, in the pre-B cell line 70Z/3,
the activation of NFkB in response to PMA has been
shown to be only transient and inhibition of protein syn-
thesis leads to a superinduction [31]. Second, in HeLa cells
briefly exposed to TNF and then maintained in its
absence, Arenzana-Seisdedos et al. [30] found a substantial
decrease in nuclear NFkB content, which was again
dependent on new protein synthesis. Third, in fibroblasts
from IkBa knockout mice, the failure to clear NFkB from
the nucleus after a short pulse of TNF directly proves the
involvement of IkBa in this process [32].
Our results also explain the observation by Wu et al. [33]
that overexpression of IkBa inhibited the function of
HIV-1 Rev and HTLV-I Rex. These authors concluded
that an essential Rev or Rex cofactor might be under
NFkB control. Although this might still be the case, our
data suggest that the inhibition of Rev and Rex results
from competition for a common nuclear-export pathway.
A working model for nuclear export
Our experiments provide insight into how nuclear export
of proteins containing NESs might occur. We have found
NES interactions with nucleoporins that are located on
the nucleoplasmic side, the pore membrane domain, and
the cytoplasmic side of the NPC. Thus, the most
straightforward model is that a NES-containing protein
moves through the NPC by sequential interactions with
more peripheral nucleoporins (Fig. 5). This is strikingly
similar to the model proposed for the nuclear import of
proteins containing NLSs [34,35]. In this model, the FG-
repeat regions of several nucleoporins spaced throughout
the NPC channel provide the stationary phase along
which the NLS–karyopherin/importin complex is translo-
cated from the cytoplasm to the nucleus. Intriguingly, an
overlapping set of repeat-containing proteins, including
Nup98, Nup153 and Nup214, appear to be involved in
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Figure 5
A working model for protein export through
the nuclear pore. Export substrate is shown in
pink, and import substrate in orange. a and b
refer to the subunits of the NLS receptor
(karyopherin/importin). 
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the binding of both import [34] and export (this study)
substrates. In this context, the nucleoplasmic, NES-
binding hRIP is analogous to the cytoplasmic, NLS-
binding karyopherina/importina. However, whereas
karyopherina/importina is a true ‘adaptor’ that shuttles
import substrates into the nucleus, hRIP does not appear
to shuttle (our unpublished observations), and itself
resembles the stationary phase by containing FG repeats. 
For both protein import and RNA export, a major question
remains over the driving force that transports substrates
through the 100 nm-long NPC. One attractive hypothesis
is that the affinity of a substrate for the stationary phase
gradually increases from one side of the NPC to the other.
Although our data do not generally support such a simple
model, it is interesting to note that the nucleoporins on the
nucleoplasmic side (Nup153 and Nup98) interact more
strongly with NESs than hRIP, and that the strongest
interaction we observe is with Nup214 on the cytoplasmic
side. Another important question is how the repeat regions
of Nup98, Nup153 and Nup214 can be involved simulta-
neously in binding NLS-containing complexes for import
and NES-containing proteins for export.
A nuclear export pathway conserved from yeast to man
Although we show that the protein-export pathway medi-
ated by leucine-rich NESs is functional in yeast, no natural
yeast substrates have been identified as yet; database
searches are hampered by the degenerate nature of the
NES consensus sequence (Fig. 1c). However, several yeast
proteins are known to shuttle between the nucleus and
cytoplasm. Furthermore, the yeast nuclear envelope does
not break down during mitosis, which necessitates the
regulated import and export of certain cell-cycle regulators.
In any case, our results indicate that yeast genetics can now
be used to elucidate the components and mechanisms of
this nuclear-export pathway.
Conclusions
We show that the pathway used by the HIV-1 Rev protein
for the export of unspliced HIV RNAs is a cellular protein-
export pathway. Cellular substrates for this pathway
include PKI, the inhibitor protein for PKA, and IkB, the
inhibitor of Rel family transcription factors. Our results
suggest a model whereby translocation of these proteins
through the nuclear pore is mediated by sequential inter-
actions with different nuclear pore proteins. We show this
pathway to be functional in yeast, and predict the
existence of yeast proteins that contain leucine-rich NESs.
Materials and methods
Plasmid constructs
The LexA–Rev, LexA–Rev mutants, LexA–Rex, hRIP and DhRIP con-
structs were as described [8]. For the LexA–PKI constructs, comple-
mentary oligonucleotides were synthesized encoding amino acids
35–47 of PKIa [10] flanked by BamHI and XhoI sites. These
BamHI–XhoI fragments were cloned into pEG202 [36]. The LexA–IkB
fusion was constructed by polymerase chain reaction (PCR) amplifica-
tion of the sequence encoding amino acids 263–281 of IkBa [33],
with oligonucleotides creating EcoRI (5′) and BamHI (3′) sites flanking
the fragment. This fragment was inserted between the EcoRI and
BamHI sites of pEG202 [36].
For the construction of Rev wild-type and M10 eukaryotic expression
vectors, EcoRI fragments obtained by PCR from pcRev and pcRevM10
[13] were cloned into the EcoRI site of pcDNAI (Invitrogen). For the
construction of RBD–NES fusion expression vectors, fragments encod-
ing amino acids 35–47 of PKIa and PKIaP12 or amino acids 263–281
of IkBa were excised by EcoRI/Klenow/XhoI treatment from the LexA
vectors and inserted into BglII/Klenow/XhoI-treated pcDNAI-RevM10,
creating fusions of the NES regions at amino acid 77 of Rev.
For the analysis of nucleoporin repeat regions in the two-hybrid assay,
the following regions (amino acids) of the nucleoporin coding
sequences were amplified by PCR and cloned into pJG4-5 [36] using
EcoRI (5′) and XhoI (3′) sites encoded by the oligonucleotides: Nup98,
1–517; Nup153, 647–1468; Pom121, 796–1199; Nup159,
451–738; and Nup214, 1611–2093. The oligonucleotides for
Nup214 were made according to the sequence in the genebank
(Accession number, D14689) that differs in the carboxyl terminus from
the sequence in [37].
The LexA–PKI–AD fusions were constructed by cloning a blunt-ended
fragment encoding the activation domain of the pseudorabies virus
immediate early protein [38] (amino acids 1–34) into XhoI/Klenow-
treated LexA–PKI fusion vectors described above.
Yeast two-hybrid and liquid b-galactosidase assays
Plasmids pairs encoding LexA-fusion proteins (pEG202 derivatives)
and activation-domain-tagged proteins (pJG4-5 derivatives) were trans-
formed simultaneously into the yeast strain CFY1, a derivative of
EGY48 containing an integrated version of pSH18-34 [36]. Transfor-
mations were carried out using the lithium-acetate method according to
[39]. Individual colonies were restreaked onto nitrocellulose filters on
glucose, His–,Trp– plates. After 24 h at 30 °C, the nitrocellulose filters
were placed onto His–,Trp– plates containing 2 % galactose, 1 % raffi-
nose, 0.1 M KPO4 pH 7.0, and 0.2 mg ml–1 X-Gal. Plates were pho-
tographed after two or three days at 30 °C. Liquid b-galactosidase
assays were done by the ‘glass bead’ method according to [40].
Transfection and CAT assays
Transfections were done using the calcium-phosphate technique
according to [41]. Transfection mixes included 1 mg of Rev derivative,
0.5 mg CAT reporter CM128, 2 mg RSV-bGal and 15 mg pGEM3 as
carrier DNA. Precipitates were left on the cells for 20 h, and cells were
harvested 48 h after the removal of the calcium-phosphate precipitate.
CAT assays were done using standard protocols [40], the amount of
extract used was adjusted to b-galactosidase activities to adjust for
transfection efficiencies.
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